$LLY makes it 5 for 5 💊 🔥🔥🔥🔥🔥
🔹 Revenue $24.4B vs $22.6B expected, up 39%
🔹 EPS $7.48 vs $6.26 expected
🔹 Mounjaro $10.7B, up 65%
🔹 Zepbound $5.35B, up 49%
🔹 Full year guide raised to $91B to $92B, from $85B to $87B
The only soft spot: the Foundayo pill did $184M vs about $229M expected.
Stock up about 3.9% premarket. The streak lives on 🔥
#stocks
🔹 Revenue $24.4B vs $22.6B expected, up 39%
🔹 EPS $7.48 vs $6.26 expected
🔹 Mounjaro $10.7B, up 65%
🔹 Zepbound $5.35B, up 49%
🔹 Full year guide raised to $91B to $92B, from $85B to $87B
The only soft spot: the Foundayo pill did $184M vs about $229M expected.
Stock up about 3.9% premarket. The streak lives on 🔥
#stocks
